Close Menu

Books in a Library

G Afsar

The Prevalence of β2 Agonist Response in Patients with Non-asthmatic Eosinophilic Bronchitis (NAEB) and Spirometric Differences among Eosinophilic Airway Disorders Associated with Corticosteroid Responsive Chronic Cough

Observing β2 agonist response is a simple procedure most likely to differentiate NAEB and CVA from AC. FEF25-75 is seem to be determinative for AHR in CVA, effectiveness of FEF25-75 rather than PEF in NAEB is considered so that NAEB may develop to CVA with time.


Background: The number of admissions to immunology and allergy clinics with chronic cough categorized as corticosteroid-responsive eosinophilic disorders are increasing. We aimed in this study to find the prevalence of Non-asthmatic eosinophilic bronchitis (NAEB), Cough variant asthma (CVA), Atopic cough (AC) and β2 agonist response among NAEB.

08 Aug, 2017
Journal Sections: 
e-Published: 21 Aug, 2017


Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Subscribe to RSS - G Afsar
Top of Page